Navigation Links
Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
Date:9/10/2007

Live Webcasts from New York on September 18th and 20th

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that Tamara Seymour, Chief Financial Officer, and David Guy, Chief Commercial Officer, will present at two upcoming investor conferences:

-- AG Edwards Emerging Growth Conference at 1:00 p.m. Eastern time on

Tuesday, September 18, 2007, from the New York Palace Hotel in New

York City; and

-- Wall Street Analyst Forum at 9:10 a.m. Eastern time on Thursday,

September 20, 2007, from the Princeton Club in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

Live webcasts of both presentations can be accessed at http://www.favrille.com. Replays will be available approximately one hour after each presentation and archived for one month.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.


'/>"/>
SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...ote on an article on "The Final Death Knell of Chi... was on the walls of the demise of Searle due to t...final remaining Searle facilities in Chicago. Sinc...in Chicago. , ,Fast forward two years to another a...thousands of jobs, Chicago,s biotech space to trip...
...t gave about $400,000 worth of software to Lad L...k youth and their families. Rob Busch, enterprise ...reception last Friday at the non-profit,s Synergy ... ,Microsoft,s software donation will be used to up...e, including the computers and software programs u...
...c Foundry posted mixed financial numbers for the e...enue while still posting a net loss. , ,Revenues w...previous fiscal year, with unit sales up 74 percen... new product offerings and increased marketing eff...t, however, and the company posted a loss of $4.2 ...
...sin is to attract the presence of major pharmaceut...focus on its own environment, said a panel assembl... Medical-Devices Association. , ,Part of building ...cting large corporations, said WBMA President and ...nior consultant with Cushman and Wakefields Busine...
Other Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5Panel stresses drawing outside biotech firms to state 2
(Date:9/5/2008)...Newswire/ -- Corporate Safe Specialists (CSS),anno...ompany has hired,Thomas P. Hartmann as Senior Dire...newscom.com/cgi-bin/prnh/20080905/AQF028 ), (Logo...F030LOGO ), Ed McGunn, President and CEO of the C...l help the company achieve its strategic objective...
(Date:9/5/2008)...onal Science Foundation has awarded Iowa State Uni....5 million grant to establish the NSF Engineering ...t Iowa State. , The award is part of the Nationa...g Research Centers (ERC) Program. The third-genera...create university and industry partnerships in res...
(Date:9/5/2008)...animals face the challenge of surviving in a chang...n and Universit Claude Bernard Lyon have shown how...t coast of Scotland responds to two consequences o...e unpredictability of winter storms. Dr. Thomas Ez...es are good and food is plentiful, lambs contribut...
(Date:9/5/2008)...nnovative work on a new type of heart stent sensor...r of mechanical engineering at Virginia Tech, a Na...elopment (CAREER) award of $400,000. , The focu...pecific models and experiments to describe what ha... has a unique type of in situ polymer strain-sensi...
Breaking Biology News(10 mins):Corporate Safe Specialists Launches International Sales Efforts 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 3Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 4Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Online Career Site Assists Academia in Its Reach 7327 1Online Career Site Assists Academia in Its Reach 7327 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 1Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 3Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 4Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 5Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 6UltraShape Appoints Assaf Eyal as President 26 CEO 7326 1UltraShape Appoints Assaf Eyal as President 26 CEO 7326 2UltraShape Appoints Assaf Eyal as President 26 CEO 7326 3Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 1Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 2Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 3
...searchers are recruiting people with backache caus...?in the first ever study to discover if therapeuti...opher McCarthy and his team at the University,s Ce... aged 22-55 who have had sciatica for less than 12... spinal surgery. , The volunteers will receive ...
...ch tools, researchers have identified three protei...ection up to 20 months before the rejection occurr...rtality rate of organ recipients, about 45% over f...t Chris Wendt. Currently, there is no reliable way...signs of chronic rejection appear, it is usually t...
... important for the survival of many types of cells... neurons ?critical brain cells that connect the ce... motor neuron diseases like amyotrophic lateral sc...ember 2006 issue of Nature Neuroscience, two inves... and the Harvard Stem Cell Institute describe how ...
...mune system controls HIV during the earliest phase...fic versions of key immune-system molecules called...on the fragments of viral protein those molecules ...infected cells. In a report in the November issue...IDS Research Center at Massachusetts General Hospi...
Other Biology News:Proteins may predict lung transplant rejection 2Proteins may predict lung transplant rejection 3Growth factor stimulates rapid extension of key motor neurons in brain 2Early-stage immune system control of HIV may depend on inherited factors 2Early-stage immune system control of HIV may depend on inherited factors 3
...Maker, 1. Modular system for large format and medi...b-cast or precast gels (26 x 20 cm) simultaneously...mple-to-use 1.0-mm or 1.5-mm pre-assembled hinged ... and unloading.Built-in ceramic heat exchanger and...
Edited by P.J. Delves (1997) An up-to-date review of antibody-raising technologies, this volume provides researchers with immediate access to the protocols they require every day.
Request Info
MOUSE ANTI HUMAN FACTOR I
Biology Products: